Proteinase specificity and functional diversity in po plasminogen activator inhibitor 1

被引:43
作者
Gils, A [1 ]
Declerck, PJ [1 ]
机构
[1] CATHOLIC UNIV LEUVEN,FAC PHARMACEUT SCI,LAB PHARMACEUT BIOL & PHYTOPHARMACOL,B-3000 LOUVAIN,BELGIUM
关键词
D O I
10.1074/jbc.272.19.12662
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasminogen activator inhibitor-1 (PAI-1) is a unique member of the serpin superfamily. The alternative behavior of PAI-1 as an inhibitor, a non-inhibitory substrate, or a non-reactive latent form has been shown to be dependent on the initial conformation. In this study, we have evaluated the effect of a substitution outside the reactive site loop (P18) or in the reactive site loop (P6 and P10) on proteinase specificity and conformational transitions in PAI-1. Wild-type PAI-1 (wtPAI-1) revealed the same conformational distribution pattern toward tissue-type plasminogen activator (t-PA) as toward urokinase-type plasminogen activator (u-PA) (i.e. 53 +/- 6.9% active, 36 +/- 6.8% latent, and 12 +/- 1.9% substrate). Inactivation of wtPAI-1 resulted in the conversion of the labile active form into the latent form while the stable substrate form remained unchanged. PAI-1-P6 (Val --> Pro at P6) revealed a target specificity for t-PA (39 +/- 7% versus 3 +/- 2% of the theoretical maximal value toward t-PA and u-PA, respectively), PAI-1-P10 (Ser --> Pro at P10) was 4-fold more active toward u-PA than toward t-PA, and PAI-1-P18 (Asn --> Pro at P18) exhibited inhibitory properties exclusively toward u-PA (41 +/- 10%). Surprisingly, inactivation of these mutants revealed functional and conformational transitions distinct from those observed for wtPAI-1. Inactivation of PAI-1-P6 (Val --> Pro) resulted in a total conversion of the active form into the latent form and in a partial conversion of the substrate form into the latent form, The active forms of both PAI-1-P10 (Ser --> Pro) and PAI-1-P18 (Asn --> Pro) are also labile but, in contrast to the active form of wtPAI-1, convert into substrate forms. Based on the existence of various conformations of PAI-1, we propose an alternative reaction scheme describing the putative interactions between serpins and their target proteinases. The unusual conformational and functional flexibility of PAI-1 that, according to the current study, appears not to be restricted to the reactive site loop further underlines the importance of potential structural rearrangements (e.g. upon binding to cofactors) in PAI-1 (or serpins in general) for its functional behavior at particular biological sites.
引用
收藏
页码:12662 / 12666
页数:5
相关论文
共 48 条
  • [1] PURIFICATION AND CHARACTERIZATION OF NATURAL AND RECOMBINANT HUMAN-PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
    ALESSI, MC
    DECLERCK, PJ
    DEMOL, M
    NELLES, L
    COLLEN, D
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 175 (03): : 531 - 540
  • [2] PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 - REACTIVE CENTER AND AMINO-TERMINAL HETEROGENEITY DETERMINED BY PROTEIN AND CDNA SEQUENCING
    ANDREASEN, PA
    RICCIO, A
    WELINDER, KG
    DOUGLAS, R
    SARTORIO, R
    NIELSEN, LS
    OPPENHEIMER, C
    BLASI, F
    DANO, K
    [J]. FEBS LETTERS, 1986, 209 (02) : 213 - 218
  • [3] AUDENAERT AM, 1994, J BIOL CHEM, V269, P19559
  • [4] DYSFUNCTIONAL C1BAR-INHIBITOR(AT), ISOLATED FROM A TYPE-II HEREDITARY-ANGIO-EDEMA PLASMA, CONTAINS A P1 REACTIVE CENTER (ARG-444-]HIS) MUTATION
    AULAK, KS
    PEMBERTON, PA
    ROSEN, FS
    CARRELL, RW
    LACHMANN, PJ
    HARRISON, RA
    [J]. BIOCHEMICAL JOURNAL, 1988, 253 (02) : 615 - 618
  • [5] Carrell R.W, 1986, PROTEINASE INHIBITOR, P403
  • [6] COOPERMAN BS, 1993, J BIOL CHEM, V268, P23616
  • [7] DECLERCK PJ, 1992, J BIOL CHEM, V267, P11693
  • [8] PATHOPHYSIOLOGY OF FIBRINOLYSIS
    DECLERCK, PJ
    JUHANVAGUE, I
    FELEZ, J
    WIMAN, B
    [J]. JOURNAL OF INTERNAL MEDICINE, 1994, 236 (04) : 425 - 432
  • [9] DERECHIN VM, 1990, J BIOL CHEM, V265, P5623
  • [10] EHRLICH HJ, 1990, J BIOL CHEM, V265, P13029